title: [American Society of Clinical Oncology (ASCO) 2012 essential data: the editorial board of the Bulletin du Cancer point of view].
abstract: We know where we are but do we know where we are going in the next future? Each year ASCO meeting leads to us hopes and dreams for the best management of our patients. With a past view over six months, we will try to highlight useful informations across the manuscript whatever the locations.
authors.affiliation: Institut de cancérologie Lucien-Neuwirth, département de radiothérapie, 108 bis, avenue Albert-Raimond, 42271 Saint-Priest-en-Jarez, France.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Magné
authors.forename: Jacques-Olivier
authors.initials: JO
authors.lastname: Bay
authors.forename: Jean-Yves
authors.initials: JY
authors.lastname: Blay
authors.forename: Anthony
authors.initials: A
authors.lastname: Gonçalves
authors.forename: Christophe
authors.initials: C
authors.lastname: Massard
authors.forename: Juliette
authors.initials: J
authors.lastname: Thariat
authors.forename: Marie
authors.initials: M
authors.lastname: Wislez
authors.forename: Thierry
authors.initials: T
authors.lastname: André
authors.forename: Stéphane
authors.initials: S
authors.lastname: Vignot
mesh_terms: D002986:Clinical Trials as Topic; D035081:Editorial Policies; D005602:France; D006801:Humans; D008495:Medical Oncology; D009369:Neoplasms / Q000628:therapy*; D010506:Periodicals as Topic; D012955:Societies, Medical; D014481:United States